IPO registrations (S-1, F-1) · Registrants
Can-Fite BioPharma Ltd.
- SEC CIK
- 1536196 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2014-04-08, last 2025-07-25; 11 initial registrations, 11 amendments
- Outcome
- Final prospectus filed 2020-02-12; declared effective 2014-04-24
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- L3
- Business address
- 26 BEN GURION STREET, Ramat Gan, L3 5257346
- Ticker
- CANF (NYSE)
- EDGAR entity type
- other
- Insiders and CEO pay
- Can-Fite BioPharma Ltd. on the corporate pages
Offering terms
- Final price
- $1.50 per ADS (424B4 filed 2020-02-12)
- Shares sold
- 1,825,000
- Gross proceeds
- $2,737,500 before underwriting discounts and any over-allotment option
- Listing
- NYSE American under the symbol CANF
- Lead underwriters
- Wainwright & Co
- Syndicate
- H.C. Wainwright
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Can-Fite BioPharma Ltd. EXACT (CIK (EXACT))
- SEC filer: Can-Fite BioPharma Ltd. EXACT (CIK (EXACT))
Filings 67
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-04-08 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001144204-14-021352 ↗ |
| 2014-04-24 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-14-001116 ↗ |
| 2014-09-29 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-14-002886 ↗ |
| 2014-10-21 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-14-003110 ↗ |
| 2015-06-23 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-15-001709 ↗ |
| 2016-01-29 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-16-003629 ↗ |
| 2017-05-30 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-17-005943 ↗ |
| 2017-06-13 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-17-001523 ↗ |
| 2017-10-11 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-17-002641 ↗ |
| 2018-04-04 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-18-000748 ↗ |
| 2018-08-08 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-18-010490 ↗ |
| 2018-08-31 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-18-012000 ↗ |
| 2018-09-10 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-18-002317 ↗ |
| 2018-09-13 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-18-002353 ↗ |
| 2019-02-15 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-19-002713 ↗ |
| 2019-03-12 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-19-003967 ↗ |
| 2019-03-22 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-19-000500 ↗ |
| 2019-05-03 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-19-007796 ↗ |
| 2019-05-28 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-19-009654 ↗ |
| 2019-06-28 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-19-011778 ↗ |
| 2019-07-12 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-19-012600 ↗ |
| 2019-10-17 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-19-020567 ↗ |
| 2019-10-18 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-19-020597 ↗ |
| 2019-10-18 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-19-002340 ↗ |
| 2020-01-24 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-20-001752 ↗ |
| 2020-02-03 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-20-002441 ↗ |
| 2020-02-10 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-20-003078 ↗ |
| 2020-02-10 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-20-000305 ↗ |
| 2020-02-12 | 424B4 | 424B4 (final prospectus) | Can-Fite BioPharma Ltd. | 0001213900-20-003343 ↗ |
| 2020-03-27 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-20-007689 ↗ |
| 2020-04-07 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-20-000692 ↗ |
| 2020-04-07 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-20-000700 ↗ |
| 2020-07-10 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-20-017222 ↗ |
| 2020-07-24 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-20-001917 ↗ |
| 2020-09-04 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-20-002368 ↗ |
| 2020-10-09 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-20-002807 ↗ |
| 2021-04-08 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-21-001347 ↗ |
| 2021-08-26 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-21-045052 ↗ |
| 2021-08-31 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-21-003361 ↗ |
| 2021-09-01 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-21-003384 ↗ |
| 2022-01-14 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-22-000153 ↗ |
| 2022-03-30 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-22-000759 ↗ |
| 2022-09-01 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-22-002568 ↗ |
| 2023-01-31 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-23-006481 ↗ |
| 2023-02-10 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-23-010298 ↗ |
| 2023-02-10 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-23-000377 ↗ |
| 2023-04-24 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-23-001021 ↗ |
| 2023-09-08 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-23-002602 ↗ |
| 2023-09-12 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-23-002642 ↗ |
| 2024-01-05 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-24-000051 ↗ |
| 2024-04-09 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-24-000899 ↗ |
| 2024-09-05 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-24-002720 ↗ |
| 2024-09-06 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-24-002747 ↗ |
| 2025-04-17 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-25-001136 ↗ |
| 2025-07-23 | F-1 | F-1 (foreign registration) | Can-Fite BioPharma Ltd. | 0001213900-25-067001 ↗ |
| 2025-07-25 | F-1/A | F-1/A (amendment) | Can-Fite BioPharma Ltd. | 0001213900-25-067666 ↗ |
| 2025-07-28 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-25-002378 ↗ |
| 2025-07-29 | 424B4 | 424B4 (final prospectus) | Can-Fite BioPharma Ltd. | 0001213900-25-068481 ↗ |
| 2025-09-11 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-25-002918 ↗ |
| 2025-09-11 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-25-002927 ↗ |
| 2026-03-31 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-26-001005 ↗ |
| 2026-03-31 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-26-001009 ↗ |
| 2026-04-03 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-26-001089 ↗ |
| 2026-09-11 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-26-002944 ↗ |
| 2026-09-11 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-26-002945 ↗ |
| 2026-10-09 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-26-003201 ↗ |
| 2026-10-09 | EFFECT | EFFECT (declared effective) | Can-Fite BioPharma Ltd. | 9999999995-26-003206 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-02-10 | F-1/A | registration statement | $33.75 | 83,333 | $2,812,488 | 0 | primary document; price line, shares headline, proceeds computed | document ↗ | ||
| 2020-02-12 | 424B4 | final prospectus | $1.50 | 1,825,000 | $2,737,500 | NYSE American CANF | 2 | primary document; price sentence, shares headline, proceeds computed, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bornstein Yoseph | Director | 1 | 2026 | ||
| Farbstein Motti | Officer | CEO, CFO and COO | 2 | 2026 | |
| Fishman Pnina | Director,Officer | Chief Scientific Officer | 2 | 2026 | |
| Fishman Sari | Officer | VP Business Development | 1 | 2026 | |
| Sartani Abraham | Director | 1 | 2026 | ||
| Regev Guy | Director | 1 | 2026 | ||
| Tamir Ilan | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-09-10 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $8,306,884 | $8,306,884 | 1 | 1 |
| 2021-12-30 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $10,000,000 | $10,000,000 | 1 | 1 |
| 2021-08-26 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $9,996,900 | $9,996,900 | 1 | 1 |
| 2020-07-17 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $3,411,000 | $3,411,000 | 3 | 1 |
| 2020-06-19 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $8,000,002 | $8,000,002 | 4 | 1 |
| 2020-01-24 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $2,400,000 | $2,400,000 | 4 | 1 |
| 2019-05-31 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $6,000,000 | $6,000,000 | 5 | 1 |
| 2019-04-11 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $3,200,000 | $3,200,000 | 2 | 1 |
| 2019-01-24 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $2,350,000 | $2,350,000 | 1 | 1 |
| 2018-03-22 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $5,000,004 | $5,000,004 | 3 | 1 |
| 2017-01-25 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $5,000,000 | $5,000,000 | 8 | 1 |
| 2015-10-28 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $4,825,002 | $4,825,002 | 3 | 1 |
| 2015-10-02 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $9,000,002 | $9,000,002 | 3 | 1 |
| 2014-12-17 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $8,000,000 | $8,000,000 | 4 | 1 |
| 2014-03-24 | Can-Fite BioPharma Ltd. | Pharmaceuticals | $5,059,072 | $5,059,072 | 16 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Can-Fite BioPharma Ltd. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Can-Fite BioPharma Ltd. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, L3 first:
- CANNAPOWDER, INC. L3
- Rosetta Genomics Ltd. L3
- BIOCANCELL THERAPEUTICS INC. L3
- RedHill Biopharma Ltd. L3
- KAMADA LTD L3
- MAPI - PHARMA LTD L3
- NeuroDerm Ltd. L3
- Advanced Inhalation Therapies (AIT) Ltd. L3
- Silenseed Ltd. L3
- SciSparc Ltd. L3
In other datasets, the same topic (Health) in L3:
- Form D issuer: Agada Medical Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health